Waldenstrom Resource TC Archives - PEN

The Pro-Active Waldenström Macroglobulinemia Patient Toolkit Resource Guide

December 15, 2022/in NHL Newly Diagnosed, NHL Resources ND, NHL Resources TC, NHL Treatments and Clinical Trials, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials, Waldenstrom's Programs, Waldenstrom's Resources TK, Waldenstrom's Toolkit /by Kara Rayburn

PEN-146_WM_TK_ResourceGuide

Participating in a Clinical Trial: What You Need to Know Resource Guide

August 15, 2022/in Adrenal Cancer, Adrenal Cancer Resource TC, Adrenal Cancer Treatment & Clinical Trials, AML Resources TC, AML Treatments and Clinical Trials, Appendix Cancer, Appendix Cancer Resources TC, Appendix Cancer Treatment & Clinical Trials, BC Resource TC, BC Treatment & Clinical Trials, Bladder Cancer Treatment and Clinical Trials, BLC Resource TC, Bone Cancer, Bone Cancer Resource TC, Bone Cancer Treatment & Clinical Trials, Brain Cancer, Brain Cancer Resource TC, Brain Cancer Treatment & Clinical Trials, Care Partner Resources Resources, CC Resource TC, CC Treatment and Clinical Trials, Clinical Trials 101, CLL Resources TC, CLL Treatments and Clinical Trials, CT 101 Guides, DLBCL Resource TC, DLBCL Treatments and Clinical Trials, Eye Cancer, Eye Cancer Resource TC, Eye Cancer Treatment & Clinical Trials, FL Resource TC, FL Treatment and Clinical Trials, Gastrointestinal Cancer, General Health Info, General Health Programs, General Resource TC, General Treatment and Clinical Trials, GNYC Treatment and Clinical Trials, GYNC Resource TC, Head & Neck Cancer Treatment & Clinical Trials, Head & Neck Resource TC, Kidney Cancer, LC Resources TC, LC Treatments and Clinical Trials, MM Resources TC, MM Treatments and Clinical Trials, MPN Resources TC, MPN Treatments and Clinical Trials, NHL Resources TC, NHL Treatments and Clinical Trials, PC Resources TC, PC Treatments and Clinical Trials, RMC Resources TC, RMC Treatment and Clinical Trials, SC Resources TC, SC Treatment and Clinical Trials, Thyroid Cancer Resource TC, Thyroid Cancer Treatment & Clinical Trials, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials /by Kara Rayburn

Webinar 2_ClinicalTrials101_Guide_F

See More from Clinical Trials 101

Could a Clinical Trial Be Your Best Cancer Treatment Option? Resource Guide

May 3, 2022/in Adrenal Cancer, Adrenal Cancer Resource TC, Adrenal Cancer Treatment & Clinical Trials, AML Resources TC, AML Treatments and Clinical Trials, Appendix Cancer, Appendix Cancer Resources TC, Appendix Cancer Treatment & Clinical Trials, BC Resource TC, BC Treatment & Clinical Trials, Bladder Cancer Treatment and Clinical Trials, BLC Resource TC, Bone Cancer, Bone Cancer Resource TC, Bone Cancer Treatment & Clinical Trials, Brain Cancer, Brain Cancer Resource TC, Brain Cancer Treatment & Clinical Trials, Care Partner Resources Resources, CC Resource TC, CC Treatment and Clinical Trials, Clinical Trials 101, CLL Resources TC, CLL Treatments and Clinical Trials, CT 101 Guides, DLBCL Resource TC, DLBCL Treatments and Clinical Trials, Eye Cancer, Eye Cancer Resource TC, Eye Cancer Treatment & Clinical Trials, FL Resource TC, FL Treatment and Clinical Trials, Gastrointestinal Cancer, General Health Info, General Health Programs, General Resource TC, General Treatment and Clinical Trials, GNYC Treatment and Clinical Trials, GYNC Resource TC, Head & Neck Cancer Treatment & Clinical Trials, Head & Neck Resource TC, Kidney Cancer, LC Resources TC, LC Treatments and Clinical Trials, MM Resources TC, MM Treatments and Clinical Trials, MPN Resources TC, MPN Treatments and Clinical Trials, NHL Resources TC, NHL Treatments and Clinical Trials, PC Resources TC, PC Treatments and Clinical Trials, RMC Resources TC, RMC Treatment and Clinical Trials, SC Resources TC, SC Treatment and Clinical Trials, Thyroid Cancer Resource TC, Thyroid Cancer Treatment & Clinical Trials, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials /by Kara Rayburn

ClinicalTrials101_DownloadableGuide

See More from Clinical Trials 101

Waldenström Macroglobulinemia Treatment Decisions: What’s Right For You? Resource Guide

March 9, 2022/in NHL Newly Diagnosed, NHL Resources ND, NHL Resources TC, NHL Treatments and Clinical Trials, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials, Waldenstrom's Programs, Waldenstrom's Resources TK, Waldenstrom's Toolkit /by Kara Rayburn

PEN-146_Castillo_ResourceGuide_F (1)

Waldenström Macroglobulinemia Patient First Office Visit Planner

March 9, 2022/in NHL Newly Diagnosed, NHL Resources ND, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials, Waldenstrom's Planners TK, Waldenstrom's Programs, Waldenstrom's Toolkit /by Kara Rayburn

PEN-146_Patient_WM_FirstOfficeVisit-Planner_F

Waldenström Macroglobulinemia Patient Follow-Up Visit Planner

March 9, 2022/in NHL Newly Diagnosed, NHL Resources ND, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials, Waldenstrom's Planners TK, Waldenstrom's Programs, Waldenstrom's Toolkit /by Kara Rayburn

PEN-146_Patient_WM_FollowUpVisit-Planner_F

Waldenström Macroglobulinemia Care Partner First Office Visit Planner

March 9, 2022/in NHL Newly Diagnosed, NHL Resources ND, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials, Waldenstrom's Planners TK, Waldenstrom's Programs, Waldenstrom's Toolkit /by Kara Rayburn

PEN-146_Caregiver_FirstOfficeVisit-Planner_F

Waldenström Macroglobulinemia Care Partner Follow-Up Visit Planner

March 9, 2022/in NHL Newly Diagnosed, NHL Resources ND, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Treatment and Clinical Trials, Waldenstrom's Planners TK, Waldenstrom's Programs, Waldenstrom's Toolkit /by Kara Rayburn

PEN-146_Caregiver_FollowUpVisit-Planner_F

Frequently Asked Questions About Waldenström Macroglobulinemia

March 3, 2022/in IWMF, Partner Resources, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Podcast T, Waldenstrom Resource ND, Waldenstrom Resource TC, Waldenstrom Testing, Waldenstrom Treatment and Clinical Trials /by Kara Rayburn

Editor’s Note: This guide was originally published by The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) here.

By Peter DeNardis, Marcia Klepac, Elena Malunis, and Linda Nelson, 2017. Revised Linda Nelson, 2019.

Frequently_Asked_Questions_English_FINAL_COVERS-022021-1

Barriers to Clinical Trial Participation

October 30, 2020/in AML Resources TC, AML Treatments and Clinical Trials, BC Resource TC, BC Treatment & Clinical Trials, Bladder Cancer Treatment and Clinical Trials, BLC Video TC, CC Treatment and Clinical Trials, CC Video TC, CLL Resources TC, CLL Treatments and Clinical Trials, FL Resource TC, Follicular Lymphoma, Gastrointestinal Cancer, General Resource TC, General Treatment and Clinical Trials, GNYC Treatment and Clinical Trials, GYNC Resource TC, Head & Neck Cancer Treatment & Clinical Trials, Head & Neck Resource TC, LC Resources TC, LC Treatments and Clinical Trials, MM Resources TC, MM Treatments and Clinical Trials, MPN Resources TC, MPN Treatments and Clinical Trials, NHL Resources TC, NHL Treatments and Clinical Trials, PC Resources TC, PC Treatments and Clinical Trials, PEN Blog, SC Resources TC, SC Treatment and Clinical Trials, Thyroid Cancer Resource TC, Thyroid Cancer Treatment & Clinical Trials, Waldenstrom, Waldenstrom Resource TC /by Kara Rayburn

What are some of the barriers to clinical trial participation? What is a virtual clinical trial? Should my doctor be speaking to me about my clinical trial options? Dana Dornsife, founder of Lazarex Cancer Foundation, speaks to the key barriers in trials and how COVID-19 has really opened the door for a lot of opportunity to engage with patients around clinical trials.

Barriers to Clinical Trial Participation

Barriers to Clinical Trial Participation from Patient Empowerment Network on Vimeo.

What is a Virtual Clinical Trial?

What is a Virtual Clinical Trial? from Patient Empowerment Network on Vimeo.

COVID and Clinical Trials

COVID and Clinical Trials: Has There Been a Shift? from Patient Empowerment Network on Vimeo.

Non-Hodgkin’s Lymphoma Resources

August 7, 2019/in FL Newly Diagnosed, FL Resource AA, FL Resource T, FL Resource TC, FL Resource WN, FL Resource WPS, Follicular Lymphoma, NHL Resources AA, NHL Resources ND, NHL Resources T, NHL Resources TC, NHL Resources WN, NHL Resources WPS, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource AA, Waldenstrom Resource T, Waldenstrom Resource TC, Waldenstrom Resource WN, Waldenstrom Resource WPS /by Kara Rayburn

Non-Hodgkin’s Lymphoma Friends

July 22, 2019/in FL Newly Diagnosed, FL Resource AA, FL Resource T, FL Resource TC, FL Resource WN, FL Resource WPS, Follicular Lymphoma, NHL HealthUnlocked, NHL Resources AA, NHL Resources ND, NHL Resources T, NHL Resources TC, NHL Resources WN, NHL Resources WPS, Non-Hodgkin's Lymphoma, Waldenstrom, Waldenstrom Newly Diagnosed, Waldenstrom Resource AA, Waldenstrom Resource T, Waldenstrom Resource TC, Waldenstrom Resource WN, Waldenstrom Resource WPS /by Caitlin McDonald

A Conversation With Becky Pleat

May 1, 2019/in AML Resources TC, CLL Resources TC, FL Resource TC, LC Resources TC, MM Resources TC, MPN Resources TC, NHL Resources TC, PC Resources TC, PEN Blog, SC Resources TC, Waldenstrom Resource TC /by Kara Rayburn

Specialty Pharmacy and the Patient Journey with Specialty Medication

In this segment of A Conversation With, Becky Pleat, PharmD, RPh the Associate Director of Medical Managed Care Oncology Specialist at Sanofi discusses specialty pharmacy and the patient journey. Becky answers the following questions:

What is a specialty drug?
What is a specialty pharmacy?
Where can patients find a specialty pharmacy?
How do patients receive a specialty medication?
Will a specialty medication be covered by a patient’s health plan?
What kinds of services and/or resources are offered at specialty pharmacies?